266 related articles for article (PubMed ID: 9750914)
21. On muscle spindles, dystonia and botulinum toxin.
Rosales RL; Dressler D
Eur J Neurol; 2010 Jul; 17 Suppl 1():71-80. PubMed ID: 20590812
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of laryngeal dystonia with botulinum toxin].
Olthoff A; Grosheva M; Reichel G; Volk GF; Laskawi R
Fortschr Neurol Psychiatr; 2017 Aug; 85(8):450-462. PubMed ID: 28841743
[TBL] [Abstract][Full Text] [Related]
23. [Dystonia: therapeutic aspects].
Papaterra Limongi JC
Arq Neuropsiquiatr; 1996 Mar; 54(1):147-55. PubMed ID: 8736161
[TBL] [Abstract][Full Text] [Related]
24. Effect of dystonia and botulinum toxin treatment on health-related quality of life.
Gudex CM; Hawthorne MR; Butler AG; Duffey P
Mov Disord; 1998 Nov; 13(6):941-6. PubMed ID: 9827619
[TBL] [Abstract][Full Text] [Related]
25. Clinical guidelines for overactive bladder.
Yamaguchi O; Nishizawa O; Takeda M; Yokoyama O; Homma Y; Kakizaki H; Obara K; Gotoh M; Igawa Y; Seki N; Yoshida M;
Int J Urol; 2009 Feb; 16(2):126-42. PubMed ID: 19228224
[No Abstract] [Full Text] [Related]
26. Treatment of dystonia.
Adam OR; Jankovic J
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S362-8. PubMed ID: 18267265
[TBL] [Abstract][Full Text] [Related]
27. New therapeutic indications for botulinum toxins.
Cordivari C; Misra VP; Catania S; Lees AJ
Mov Disord; 2004 Mar; 19 Suppl 8():S157-61. PubMed ID: 15027069
[TBL] [Abstract][Full Text] [Related]
28. Medical treatment of dystonia.
Jankovic J
Mov Disord; 2013 Jun; 28(7):1001-12. PubMed ID: 23893456
[TBL] [Abstract][Full Text] [Related]
29. Treatment of cervical dystonia with botulinum toxin.
Jankovic J
Mov Disord; 2004 Mar; 19 Suppl 8():S109-15. PubMed ID: 15027062
[TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin therapy in exotropia.
Ing MR
Ophthalmology; 1999 Jun; 106(6):1045-6. PubMed ID: 10366068
[No Abstract] [Full Text] [Related]
31. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.
Bonanni L; Thomas A; Varanese S; Scorrano V; Onofrj M
Mov Disord; 2007 Oct; 22(14):2097-103. PubMed ID: 17685467
[TBL] [Abstract][Full Text] [Related]
32. Movement, visceral and autonomic disorders: use of botulinum toxin.
Moore AP
Hosp Med; 2003 Aug; 64(8):452-9. PubMed ID: 12958755
[TBL] [Abstract][Full Text] [Related]
33. [Use of botulinum toxin in the treatment of laryngeal dystonia (spasmodic dysphonia): preliminary study of twelve patients].
Teive HA; Scola RH; Werneck LC; Quadros Ad ; Gasparetto EL; Sá DS; Brandi IV; Macedo Filho ED
Arq Neuropsiquiatr; 2001 Mar; 59(1):97-100. PubMed ID: 11299440
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the symptomatic treatment of residual neurological symptoms in Wilson disease.
Hölscher S; Leinweber B; Hefter H; Reuner U; Günther P; Weiss KH; Oertel WH; Möller JC
Eur Neurol; 2010; 64(2):83-7. PubMed ID: 20606453
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of dystonia].
Mezaki T
No To Shinkei; 2005 Nov; 57(11):973-82. PubMed ID: 16363636
[No Abstract] [Full Text] [Related]
36. [New applications of botulinum toxin].
López del Val LJ; Morales Asín F
Neurologia; 1998 Oct; 13(8):388-94. PubMed ID: 9859671
[No Abstract] [Full Text] [Related]
37. [Botulinum toxin in urology].
Gamé X; Karsenty G
Prog Urol; 2006 Nov; 16(4 Suppl FMC):24-7. PubMed ID: 17183968
[No Abstract] [Full Text] [Related]
38. Delayed-onset focal dystonia of the leg secondary to traumatic brain injury.
Kemp S; Kim SD; Cordato DJ; Fung VS
J Clin Neurosci; 2012 Jun; 19(6):916-7. PubMed ID: 22341145
[TBL] [Abstract][Full Text] [Related]
39. Joint hypermobility syndrome: a risk factor for fixed dystonia?
Kassavetis P; Batla A; Pareés I; Saifee TA; Schrag A; Cordivari C; Bhatia KP; Edwards MJ
Mov Disord; 2012 Jul; 27(8):1070. PubMed ID: 22532260
[No Abstract] [Full Text] [Related]
40. Dystonias and botulinum toxin.
Khadilkar SV
J Assoc Physicians India; 2003 May; 51():443-4. PubMed ID: 12974422
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
